Meanwhile, HMGCS2 transcription is negatively regulated by mechanistic target of rapamycin complex 1 (mTORC1) kinase [52,53] and tumor-derived interleukin-6 (IL-6) [54], presumably suppressing PPARα. The gene discussed is HMGCS2; the disease is neoplasm.